In addition, the treatment improved antioxidant enzymes (GSH and GST) and decreased LPO and iNOS, thus preventing oxidative stress and free radical generation, halting the progression of STZ-mediated DN, and hence attenuating neurodegeneration and neuroinflammation. This evidence concerns the gene NOS2 and liver dysplastic nodule.